Delivery Order SPE2DB22D3301-SPE2DB25FY5TR

Award Date 6/4/25
Potential Completion Date 6/5/25
Potential Value $23K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Injectafer, a 750 mg/15 mL injectable medication. The $2,414.43 firm fixed-price delivery order has a completion date of November 25, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
The federal contract award is for the delivery of Injectafer 750 mg/15 ml vials, a pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The $17,159.20 firm fixed price delivery order has a completion date of June 12, 2025 and was awarded on June 11, 2025 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is not set aside and is an open competition. Amerisourcebergen Drug Corp holds a substantial...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,907.20 firm fixed-price delivery order is for the supply of Injectafer, a 750 mg/15 ml vial medication, with a period of performance through January 15, 2025. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of Injectafer 750 mg/15 ml vials. The contract is a Delivery Order with a Firm Fixed Price of $26,309.19 and a period of performance through February 3, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,518.76 firm fixed-price delivery order is for Injectafer 750 mg/15 ml vials, with a period of performance through November 13, 2024. The award is not designated as a set-aside contract. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a federal contract award issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $23,850.63, is for the delivery of Injectafer 750 mg/15 ml vials. This is a firm fixed-price delivery order contract with a completion date of January 9, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,408.41 firm-fixed-price delivery order is for the supply of Injectafer 750 mg/15 ml vials, with a period of performance through March 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which...
This federal contract award to Amerisourcebergen Drug Corp (DUNS: TGxsdkVQRGhOYUpNR001SFhYREdNdz09) is a Delivery Order under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $9,456.06. The award is for the pharmaceutical product Injectafer (750 mg/15 ml vial, 15 ml), with an ultimate completion date of November 25, 2024. This IDC, valued at $999,999,999 and running through November 2026, serves as a primary vehicle for the DLA to...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,469.23, is a delivery order for the injectable medication Injectafer 750 mg/15 ml vial. The contract has a completion date of February 26, 2025 and uses a firm fixed price pricing type. This contract award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $20,418.34, is for the delivery of Injectafer 750 mg/15 ml vials. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB25FY5TR
    Delivery Order

This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of Injectafer 750 mg/15 ml vial (15 ml) to the Defense Logistics Agency. The $22,558.15 firm fixed-price delivery order has a completion date of June 5, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This contract allows for multiple delivery orders across different therapeutic categories, positioning Amerisourcebergen as a critical vendor in supporting federal medical procurement needs, particularly for military and veteran healthcare systems. The award is not set-aside.

Generated 9/3/25, 10:00 AM